Express Scripts and FTC Announce Settlement

February 12, 2026

EGWP marketplace medicaid Medicare

On Feb. 4, Express Scripts and the Federal Trade Commission (FTC) announced a comprehensive resolution settlement that addresses concerns raised by the FTC. Details of the global settlement include:

  • As enforced by the settlement, our new, transparent pharmacy benefits model ensures that our patients pay the lowest available cost for their medicines, whether it is our negotiated cost, their copay, or a cash discount price.
  • TrumpRx pricing will be covered for our members so that purchases through TrumpRx will count towards their deductible upon relevant legal and regulatory changes.
    • Express Scripts is the first PBM to partner with TrumpRx, and this would be the first time TrumpRx pricing is available to patients as part of their pharmacy benefits.
  • Ensure Express Scripts’ new industry-leading and transformative price discount (rebate-free) model is widely available to employers and health plan sponsors to lower the cost of all brand medications for their members as our new standard model.
  • Ensure our new reimbursement model based off the pharmacy’s actual acquisition costs is available to retail community pharmacies, and that retail community pharmacies are compensated for other essential clinical services (e.g., certain diagnostic testing and vaccinations).
  • Ensure more lower-priced medicines, including insulins, are covered across all Express Scripts standard formularies – and that our Patient Assurance Program that caps the monthly cost of insulin at $25 is the standard for Express Scripts’ clients.
  • Support the American economy by moving rebate contracting operations conducted on Express Scripts’ behalf to the U.S. 

These are meaningful steps toward making prescription drugs more affordable for millions of families and advancing the goals we share with the administration of full transparency into prescriptions drug costs. This settlement enables us to keep moving forward, and we appreciate the Administration’s reinforcement of our commitment to pharmacy benefits that put Americans first.

legislation

Virginia and Hawaii Introduce PDAB Legislation

The Virginia Senate introduced a bill to establish a Prescription Drug Affordability Board (PDAB) to review drugs with a wholesale acquisition cost (WAC) of $60,000 or more per year or a WAC increase of $3,000 or more in any 12-month period. For drugs deemed to cause an affordability challenge, the legislation authorizes the PDAB to […]
read more >

February 12, 2026

EGWP marketplace medicaid Medicare

Solutions

AHIP Shares Update on Plan Progress to Simplify Prior Authorization

AHIP shared progress on the voluntary, multi-year commitments made by AHIP, BCBSA, and leading health plans (including Cigna Healthcare) to streamline and simplify prior authorization. Health plans serving nearly 270 million Americans are participating in this initiative. The 2026 commitments took effect on Jan. 1 and include: reducing the scope of claims subject to prior […]
read more >

February 12, 2026

EGWP marketplace medicaid Medicare

legislation

DOL Issues Proposed Rule on Improving Transparency into PBM Fees

Pursuant to President Trump’s Executive Order “Lowering Drug Prices by Once Again Putting Americans First,” the Department of Labor’s (DOL’s) Employee Benefits Security Administration (EBSA) issued a proposed rule that would require providers of PBM services and affiliated entities of brokerage and consulting services to disclose direct and indirect compensation to their self-funded ERISA fiduciary […]
read more >

February 12, 2026

EGWP marketplace medicaid Medicare

You may also like